
Sign up to save your podcasts
Or


Stanford’s Peptide Predictor algorithm scanned all 20,000 human protein-coding genes and found a natural appetite peptide that outperformed GLP-1 tenfold, as UK financial regulators joined the transatlantic Mythos emergency response.
https://sharedsapience.com/the-century-report-april-13-2026/
The discovery mechanism is the deeper story. Traditional drug development starts with a known target and works backward to find compounds. Here, an AI system reversed the process: computational scanning of the entire human proteome to identify what evolution had already produced but human researchers had never isolated. BRP existed in every human body all along. A companion Stanford study found that roughly 10% of the population carries genetic variants conferring GLP-1 resistance, rendering drugs like Ozempic less effective - meaning AI-driven discovery and precision genomics are advancing in parallel, each making the other more powerful.
A Weizmann Institute study published in Science found that genetics account for approximately 50% of human lifespan variation, at least double previous estimates, overturning a fifty-year scientific consensus. The implications ripple through every longevity and aging research program worldwide. Meanwhile, Allogene Therapeutics reported that its off-the-shelf CAR-T therapy achieved minimal residual disease negativity in 58% of lymphoma patients versus 16% with standard care.
The Mythos cybersecurity arc crossed the Atlantic as UK financial regulators - Bank of England, Financial Conduct Authority, Treasury, and National Cyber Security Centre - convened urgent talks with major banks, extending the emergency coordination that began with the U.S. Treasury summit days earlier. Two continents, one week, the same capability class. Fortescue announced acceleration of its Pilbara green grid to 290 MW by early next year, targeting full 2 GW completion by 2028 to eliminate fossil fuels from its entire mining operation. Rolls-Royce SMR secured nearly £600 million from the UK’s national wealth fund to begin construction of small modular reactors at Wylfa. And a second armed attack on Sam Altman’s residence within 48 hours of the first underscored the intensifying physical friction of the intelligence era.
Additional Reading:
* ScienceDaily - Stanford Scientists Discover “Natural Ozempic” Without Side Effects: https://www.sciencedaily.com/releases/2026/04/260412221946.htm
* ScienceDaily - Scientists Were Wrong About Lifespan - Genes Matter Way More: https://www.sciencedaily.com/releases/2026/04/260411022047.htm
* Global Banking & Finance Review - UK Regulators Assess Risks of Anthropic’s New AI Model: https://www.globalbankingandfinance.com/uk-financial-regulators-rush-assess-risks-anthropic-latest/
* International Mining - Fortescue Accelerating Real Zero Ambitions: https://im-mining.com/2026/04/13/fortescue-accelerating-real-zero-ambitions-as-it-plans-for-tech-commercialisation/
* Shared Sapience - The Century Report March 30, 2026 (Lilly AI Drug Deal): https://sharedsapience.com/the-century-report-march-30-2026/
Want to track and verify all the “everything is changing” claims I’m making? I just launched a public Progress & Claims Tracker that logs breakthroughs, slowdowns, and outright contradictions, so my own theses can be challenged by the evidence in real time. Check it out. And hey, why not subscribe while you’re there?https://sharedsapience.com/progress-and-claims-tracker/
The Century Report is a relentlessly optimistic daily briefing on AI, science, energy, and the systems reshaping civilization - grounded by rigorous evidence from the stories of exponential progress happening every single day. Completely free. New release daily. Archives can be found at the link below. Subscribe to get TCR delivered daily directly to your inbox.
https://sharedsapience.com/century-report/
The Shared Sapience Substack:
Want to get started with learning about or working with AI?
I’ve helped hundreds of clients with their own journeys into this brave new world, and I can help you too. If you’re interested in personalized guidance, consulting, or workshops, reach out to me at [email protected]
FOLLOW SHARED SAPIENCE ON SOCIAL:
Bluesky: https://bsky.app/profile/sharedsapience.substack.com
Facebook: https://www.facebook.com/sharedsapience
Instagram: https://www.instagram.com/sharedsapience/
LinkedIn: https://www.linkedin.com/company/shared-sapience/
Threads: https://www.threads.com/@sharedsapience
TikTok: https://www.tiktok.com/@sharedsapience
X (Twitter): https://x.com/SharedSapience
SUBSCRIBE TO THE PODCAST:
YouTube: https://www.youtube.com/@SharedSapience/podcasts
RSS: https://podcast.sharedsapience.com/podcast/rss.xml
Spotify:
Apple:
By Ben LinfordStanford’s Peptide Predictor algorithm scanned all 20,000 human protein-coding genes and found a natural appetite peptide that outperformed GLP-1 tenfold, as UK financial regulators joined the transatlantic Mythos emergency response.
https://sharedsapience.com/the-century-report-april-13-2026/
The discovery mechanism is the deeper story. Traditional drug development starts with a known target and works backward to find compounds. Here, an AI system reversed the process: computational scanning of the entire human proteome to identify what evolution had already produced but human researchers had never isolated. BRP existed in every human body all along. A companion Stanford study found that roughly 10% of the population carries genetic variants conferring GLP-1 resistance, rendering drugs like Ozempic less effective - meaning AI-driven discovery and precision genomics are advancing in parallel, each making the other more powerful.
A Weizmann Institute study published in Science found that genetics account for approximately 50% of human lifespan variation, at least double previous estimates, overturning a fifty-year scientific consensus. The implications ripple through every longevity and aging research program worldwide. Meanwhile, Allogene Therapeutics reported that its off-the-shelf CAR-T therapy achieved minimal residual disease negativity in 58% of lymphoma patients versus 16% with standard care.
The Mythos cybersecurity arc crossed the Atlantic as UK financial regulators - Bank of England, Financial Conduct Authority, Treasury, and National Cyber Security Centre - convened urgent talks with major banks, extending the emergency coordination that began with the U.S. Treasury summit days earlier. Two continents, one week, the same capability class. Fortescue announced acceleration of its Pilbara green grid to 290 MW by early next year, targeting full 2 GW completion by 2028 to eliminate fossil fuels from its entire mining operation. Rolls-Royce SMR secured nearly £600 million from the UK’s national wealth fund to begin construction of small modular reactors at Wylfa. And a second armed attack on Sam Altman’s residence within 48 hours of the first underscored the intensifying physical friction of the intelligence era.
Additional Reading:
* ScienceDaily - Stanford Scientists Discover “Natural Ozempic” Without Side Effects: https://www.sciencedaily.com/releases/2026/04/260412221946.htm
* ScienceDaily - Scientists Were Wrong About Lifespan - Genes Matter Way More: https://www.sciencedaily.com/releases/2026/04/260411022047.htm
* Global Banking & Finance Review - UK Regulators Assess Risks of Anthropic’s New AI Model: https://www.globalbankingandfinance.com/uk-financial-regulators-rush-assess-risks-anthropic-latest/
* International Mining - Fortescue Accelerating Real Zero Ambitions: https://im-mining.com/2026/04/13/fortescue-accelerating-real-zero-ambitions-as-it-plans-for-tech-commercialisation/
* Shared Sapience - The Century Report March 30, 2026 (Lilly AI Drug Deal): https://sharedsapience.com/the-century-report-march-30-2026/
Want to track and verify all the “everything is changing” claims I’m making? I just launched a public Progress & Claims Tracker that logs breakthroughs, slowdowns, and outright contradictions, so my own theses can be challenged by the evidence in real time. Check it out. And hey, why not subscribe while you’re there?https://sharedsapience.com/progress-and-claims-tracker/
The Century Report is a relentlessly optimistic daily briefing on AI, science, energy, and the systems reshaping civilization - grounded by rigorous evidence from the stories of exponential progress happening every single day. Completely free. New release daily. Archives can be found at the link below. Subscribe to get TCR delivered daily directly to your inbox.
https://sharedsapience.com/century-report/
The Shared Sapience Substack:
Want to get started with learning about or working with AI?
I’ve helped hundreds of clients with their own journeys into this brave new world, and I can help you too. If you’re interested in personalized guidance, consulting, or workshops, reach out to me at [email protected]
FOLLOW SHARED SAPIENCE ON SOCIAL:
Bluesky: https://bsky.app/profile/sharedsapience.substack.com
Facebook: https://www.facebook.com/sharedsapience
Instagram: https://www.instagram.com/sharedsapience/
LinkedIn: https://www.linkedin.com/company/shared-sapience/
Threads: https://www.threads.com/@sharedsapience
TikTok: https://www.tiktok.com/@sharedsapience
X (Twitter): https://x.com/SharedSapience
SUBSCRIBE TO THE PODCAST:
YouTube: https://www.youtube.com/@SharedSapience/podcasts
RSS: https://podcast.sharedsapience.com/podcast/rss.xml
Spotify:
Apple: